The Journal of Urology
Volume 178, Issue 4 , Pages 1164-1170 , October 2007

Contrast Medium Induced Nephropathy in Urological Practice

Received 30 November 2006

References 

  1. Katzberg RW. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology. 1997;204:297
  2. Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant. 2005;20:1542
  3. Savazzi G, Cusmano F, Allegri L, Garini G. Physiopathology, clinical aspects and prevention of renal insufficiency caused by contrast media. Recenti Prog Med. 1997;88:109
  4. Lewis-Jones HG, Lamb GH, Hughes PL. Can ultrasound replace the intravenous urogram in preliminary investigation of renal tract disease? (A prospective study). Br J Radiol. 1989;62:977
  5. Dalla Palma L. What is left of i. v. urography?. Eur Radiol. 2001;11:931
  6. Smith RC, Verga M, McCarthy S, Rosenfield AT. Diagnosis of acute flank pain: value of unenhanced CT. AJR Am J Roentgenol. 1996;166:97
  7. Perlman ES, Rosenfield AT, Wexler JS, Glickman MG. CT urography in the evaluation of urinary tract disease. J Comput Assist Tomogr. 1996;20:620
  8. McNicholas MMJ, Raptopoulos VD, Schwartz RK, Sheiman RG, Zormpala A, Prassopoulos PK, et al. Excretory phase CT urography for opacification of the urinary collecting system. AJR Am J Roentgenol. 1998;170:1261
  9. Meschi M, Detrenis S, Musini S, Strada E, Savazzi G. Facts and fallacies concerning the prevention of contrast medium-induced nephropathy. Crit Care Med. 2006;34:2060
  10. McCullough P. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular interventions. Catheter Cardiovasc Interv. 2006;67:335
  11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31
  12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461
  13. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with mild-to-moderate impairment of kidney function. Nephrol Dial Transplant. 2006;21:1855
  14. Cartabellotta A, Montalto G, Notarbartolo A. Evidence-based medicine (How to use biomedical literature to solve clinical problems). Italian Group on Evidence-Based Medicine-GIMBE Minerva Med. 1998;89:105
  15. Thomsen HS. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media. Eur J Radiol. 2006;60:307
  16. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int. 2006;69(suppl.):S11
  17. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerky MW, Glazier S, et al. Impact of nephropathy after percutaneous coronary interventions and a method for risk stratification. Am J Cardiol. 2004;93:1515
  18. Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology. 2006;239:392
  19. Cramer BC, Parfrey PS, Hutchkinson TA, Baron D, Melanson DM, Ethier RE, et al. Renal function following infusion of radiologic contrast material. Arch Intern Med. 1985;145:87
  20. Heller CA, Knapp J, Halliday J, O’Connell D, Heller RF. Failure to demonstrate contrast nephrotoxicity. Med J Aust. 1991;155:329
  21. Moore RD, Steinberg EP, Powe NR, Brinker JA, Fishman EK, Graziano S, et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology. 1992;182:649
  22. Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol. 2006;41:815
  23. Teruel JL, Marcen R, Onaindia JM, Serrano A, Quereda C, Ortuno J. Renal function impairment caused by intravenous urography (A retrospective study). Arch Intern Med. 1981;141:1271
  24. Newhouse JH, Landman J, Lang E, Amis ES, Goldman S, Khazan R, et al. Efficacy and safety of iopromide for excretory urography. Invest Radiol. 1994;29:S68
  25. Lundqvist S, Holmberg G, Jakobsson G, Lithner F, Skinningsrud K, Stegmayr B, et al. Assessment of possible nephrotoxicity from iohexol in patients with normal and impaired renal function. Acta Radiol. 1998;39:362
  26. Carraro M, Malalan F, Antonione R, Stacul F, Cova M, Petz S, et al. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial. Eur Radiol. 1998;8:144
  27. Myers JH, Witten DM. Acute renal failure after excretory urography in multiple myeloma. Am J Roentgenol Radium Ther Nucl Med. 1971;113:583
  28. McCarthy CS, Becker JA. Multiple myeloma and contrast media. Radiology. 1992;183:519
  29. Martinez-Maldonado M, Kumjian DA. Acute renal failure due to urinary tract obstruction. Med Clin North Am. 1990;74:919
  30. Cirit M, Toprak O, Yesil M, Bayata S, Postaci N, Pupim L, et al. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Pract. 2006;104:c20
  31. Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Indian Heart J. 1999;51:521
  32. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract. 2003;93:C29
  33. Toprak O, Cirit M, Yesil M, Bayata S, Tanrisev M, Varol U, et al. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant. 2007;22:819
  34. Mueller C, Buerkle G, Buetter HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162:329
  35. Noroozian M, Cohan RH, Caoili EM, Cowan NC, Ellis JH. Multislice CT urography: state of the art. Br J Radiol. 2004;77:S74
  36. Solomon R, Werner C, Mann D, D’Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416
  37. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the U. S. Food and Drug Administration. Radiology. 1997;203:605
  38. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both (A prospective controlled study). N Engl J Med. 1989;320:143
  39. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol. 1991;157:49
  40. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259
  41. Toprak O, Cirit M, Yesil M, Byrne DW, Postaci N, Bayata S, et al. Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment. Kidney Blood Press Res. 2006;29:2
  42. Conen D, Buerkle G, Perruchoud AP, Buettner HJ, Mueller C. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention. Int J Cardiol. 2006;110:237
  43. Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S. Hyperuricemia as a risk for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv. 2006;67:227
  44. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int. 1995;47:254
  45. Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int. 2005;68:2256
  46. Solomon R, Dumouchel W. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects. Invest Radiol. 2006;41:651
  47. Liss P, Persson PB, Hansell P, Lagerqvist B. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int. 2006;70:1811
  48. Nyman U, Almen T, Aspelin P, Hellstrom M, Kristiansson M, Sterner G. Contrast medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min. Acta Radiol. 2005;46:830
  49. Bagshaw SM, McAlister FA, Manns BJ, Ghali WA. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med. 2006;166:161
  50. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349:1333

PII: S0022-5347(07)01404-8

doi: 10.1016/j.juro.2007.05.133

The Journal of Urology
Volume 178, Issue 4 , Pages 1164-1170 , October 2007

Article Tools

* Image Usage & Resolution